November 11, 2019 - Non-regulatory SynAct receives approval from the Swedish Medical Product Agency and the Swedish Ethical Review Authority regarding the clinical Phase IIa study with AP1189
February 25, 2019 - Non-regulatory John Haurum and Terje Kalland are proposed as new members of the Board of Directors in SynAct Pharma AB
